Tag archive for ‘MS’
Gil Tanenbaum On Monday, May 18th, 2015

Australian Haredi Woman Facing Extradition from Israel For Abusing Children

– – Malka Leifer, the former principal of Adass Israel school for girls in Melbourne, is facing extradition back to Australia on charges that she had abused her students for years. She has been More...

Globes On Monday, January 26th, 2015

Teva gets first “Sell” recommendation

Berenberg analysts see insurance companies pressuring MS patients to switch to generic versions of Copaxone. Last year, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) posted its highest return More...

Gil Tanenbaum On Wednesday, December 17th, 2014

Israeli Bio Med Firm Mapi Pharma Makes Headway In MS Medication

Israeli biomed firm Mapi Pharma Ltd., which is a development stage pharmaceutical company, announced that the first patient was treated in the company’s Phase IIa study of a new drug for the treatment More...

Vered Weiss On Wednesday, December 3rd, 2014

Jim Cramer Says Janet Yellen Made the Worst Stock Call Ever

Jim Cramer discussed his stock picks on CNBC’s Mad Dash segment. Cramer said Fed Chief Janet Yellen made the worst stock call he has ever heard when she made bearish statement about the biotech sector More...

Gil Tanenbaum On Thursday, November 13th, 2014

Teva’s MS Drug Copaxone Looking for Approval in Japan

Teva’s Copaxone, a new medication under development for the treatment of multiple sclerosis treatment Copaxone, has gotten closer to getting approval for marketing in Japan from that nation’s regulatory More...

Jewish Business News Correspondent On Thursday, September 11th, 2014

Teva finds double-dose Copaxone halves side-effects

– A 50% reduction in adverse side-effects was reported with the three-times-a-week 40 mg MS injection. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has published results More...

Shiri Habib-Valdhorn On Monday, September 1st, 2014

UBS: Teva hiked Copaxone price 9.9%

– Teva is battling generic versions of the 20 mg and 40 mg dosages of its MS blockbuster. –   In the absence of generic competition to its multiple sclerosis treatment Copaxone, Teva Pharmaceutical More...

Gil Tanenbaum On Saturday, August 23rd, 2014

Ginger Software Lets Everyone in the World Communicate in English

Israeli startup Ginger, which develops software solutions, has announced the launch of a new app for students. Ginger declares that its mission is to remove language barriers between all types of people More...

Jewish Business News On Friday, August 22nd, 2014

Growing up poor affects adults’ sense of control, impulsiveness when faced with economic uncertainty

– Different perceptions of control affects ability to delay gratification, study shows   Growing up poor can influence people’s sense of control and in turn may lead them to more impulsive More...

Jewish Business News On Sunday, August 3rd, 2014

Kadimastem to collaborate with Merck Serono

–   Israeli biotechnology company Kadimastem (TASE: KDST) has signed a collaboration agreement with Merck to carry out drug screening in the neurodegenerative diseases space for multiple sclerosis More...

Wordpress site Developed by Fixing WordPress Problems